Martine De Vos
- Infectious Diseases top 0.1%
- Epidemiology top 0.5%
- Molecular Biology top 2%
- Genetics top 0.5%
- Surgery top 1%
- Co-authors
- Henri A. VerbrughHeiman WertheimAlex van BelkumDamian C. Melles∗Jan NouwenWillem van LeeuwenDebby LaukensChristina M. J. E. Vandenbroucke‐Grauls
- Topics
- Inflammatory Bowel Disease (65 papers)Bacterial Identification and Susceptibility Testing (51 papers)Antimicrobial Resistance in Staphylococcus (50 papers)
- Partner nations
- NetherlandsBelgiumFrance
In The Last Decade
Martine De Vos
327 papers receiving 15.2k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Infectious Diseases 5.5k
- Epidemiology 4.0k
- Molecular Biology 3.4k
- Genetics 3.0k
- Surgery 2.6k
Countries citing papers authored by Martine De Vos
This map shows the geographic impact of Martine De Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine De Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine De Vos more than expected).
Fields of papers citing papers by Martine De Vos
This network shows the impact of papers produced by Martine De Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine De Vos. The network helps show where Martine De Vos may publish in the future.
Co-authorship network of co-authors of Martine De Vos
This figure shows the co-authorship network connecting the top 25 collaborators of Martine De Vos. A scholar is included among the top collaborators of Martine De Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martine De Vos. Martine De Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 4 | |
| 9 | 10 | |
| 10 | Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD). | 3 |
| 11 | [Outbreaks related to contaminated duodenoscopes: causes and solutions]. | 1 |
| 12 | Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab. | 7 |
| 13 | 110 | |
| 14 | 12 | |
| 15 | 9 | |
| 16 | GPR84 inhibition as a novel therapeutic approach in IBD: mechanistic and translational studies | 1 |
| 17 | Brengt ultraschone lucht op de OK meer veiligheid | 7 |
| 18 | The ideal management of Crohn's disease: Top down versus step up strategies, a randomized controlled trial | 29 |
| 19 | A randomized controlled trial evaluating the ideal medical management for Crohn's disease (CD): Top-down versus step-up strategies | 24 |
| 20 | 22 |
About Martine De Vos
Martine De Vos is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 346 papers that have together received 15.8k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (65 papers), Bacterial Identification and Susceptibility Testing (51 papers) and Antimicrobial Resistance in Staphylococcus (50 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (828 citations), Infectious Diseases (5.5k citations) and Clinical Biochemistry (2.0k citations). Martine De Vos has collaborated with scholars based in Netherlands, Belgium and France. Frequent co-authors include Henri A. Verbrugh, Heiman Wertheim, Alex van Belkum, Damian C. Melles∗, Jan Nouwen, Willem van Leeuwen, Debby Laukens, Christina M. J. E. Vandenbroucke‐Grauls, Séverine Vermeire and Anne F. Voor in ’t holt. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.